These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6386039)

  • 21. The presence of an estrogen-regulated protein detected by monoclonal antibody in abnormal human endometrium.
    Ciocca DR; Puy LA; Edwards DP; Adams DJ; McGuire WL
    J Clin Endocrinol Metab; 1985 Jan; 60(1):137-43. PubMed ID: 3880561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical study of the distribution of secretory component and IgA in the normal and diseased uterine mucosa.
    Arends JW; Groniowski MM; de Koning Gans HJ; Bosman FT
    Int J Gynecol Pathol; 1983; 2(2):171-81. PubMed ID: 6354948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silver-stained nucleolar organizer regions in the normal, hyperplastic and neoplastic endometrium.
    Niwa K; Yokoyama Y; Tanaka T; Mori H; Mori H; Tamaya T
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(6):493-7. PubMed ID: 1721473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
    Inoue M; Saitoh J; Abe Y; Inoue Y; Ueda G; Tanizawa O; Gamoh Y; Dan A; Satoh T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2411-4. PubMed ID: 3865972
    [No Abstract]   [Full Text] [Related]  

  • 25. CD44 expression in normal, hyperplastic, and malignant endometrium.
    Saegusa M; Hashimura M; Okayasu I
    J Pathol; 1998 Mar; 184(3):297-306. PubMed ID: 9614383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple serum markers in patients with endometrial cancer.
    Panici PB; Scambia G; Baiocchi G; Perrone L; Greggi S; Battaglia F; Mancuso S
    Gynecol Obstet Invest; 1989; 27(4):208-12. PubMed ID: 2744625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pattern of epithelial mucin secretion in normal, hyperplastic, and adenocarcinomatous endometrium.
    Lurie M; Elmalach I; Weill S
    Gynecol Oncol; 1988 Jun; 30(2):274-84. PubMed ID: 2453400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of CEA, CA 19-9 and HMFG antigens in ovarian clear-cell and endometrioid carcinomas.
    Helle M; Helin H; Ashorn P; Putkinen EL; Krohn K; Wahlström T
    Pathol Res Pract; 1992 Feb; 188(1-2):74-7. PubMed ID: 1594502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of immunohistochemical demonstration of several epithelial markers in hyperplastic and neoplastic endometrium.
    Nakopoulou L; Minaretzis D; Tsionou C; Mastrominas M
    Gynecol Oncol; 1990 Jun; 37(3):346-53. PubMed ID: 2351318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
    Lin Z; Cho S; Jeong H; Kim H; Kim I
    J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immuno-pathological studies of the human endometrium].
    Okamoto G
    Igaku Kenkyu; 1970 Mar; 40(2):165-77. PubMed ID: 4920456
    [No Abstract]   [Full Text] [Related]  

  • 33. FHIT expression in neoplastic, hyperplastic, and normal endometrium.
    Ozkara SK; Corakçi A
    Int J Gynecol Cancer; 2005; 15(6):1081-8. PubMed ID: 16343185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nonsialylated high-molecular-weight glycoprotein defined by a monoclonal antibody to adenocarcinoma of the uterine endometrium.
    Inoue M; Sasagawa T; Shimizu C; Shimizu H; Saito J; Ueda G; Tanizawa O
    Gynecol Oncol; 1989 Jun; 33(3):344-50. PubMed ID: 2656426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MSN-1 antibody in the evaluation of female genital tract adenocarcinomas.
    Poropatich C; Nozawa S; Rojas M; Chapman WB; Silverberg SG
    Int J Gynecol Pathol; 1990; 9(1):73-9. PubMed ID: 2294065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNFalpha expression in hyperplastic endometrium.
    Zupi E; Sbracia M; Marconi D; Alò P; Atzei G; Brazolin T; Arduini D; Romanini C
    Am J Reprod Immunol; 2000 Sep; 44(3):153-9. PubMed ID: 11028902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of MAM-3 and MAM-6 antigens in endometrial and endocervical adenocarcinomas.
    Tsubura A; Morii S; Hilkens J; Hilgers J
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(1):59-67. PubMed ID: 3925626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis in normal, hyperplastic, and neoplastic endometrium.
    Morgan KG; Wilkinson N; Buckley CH
    J Pathol; 1996 Jul; 179(3):317-20. PubMed ID: 8774489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Altered expression of Lewis antigens associated with malignant transformation in endometrial tissues].
    Inoue M; Sasagawa T; Shimizu C; Shimizu H; Saito J; Ueda G; Tanizawa O; Nakayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1425-31. PubMed ID: 3049851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.